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ABSTRACT We report a method for generating Drosophila germline mutants effectively via injection of the
complex of the puriﬁed Cas9 protein, tracrRNA, and gene-speciﬁc crRNAs, which may reduce delayed
mutations because of the transient activity of the Cas9 protein, combined with the simple mutation
detection in GO founders by the T7E1 assay.
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In the past few years, new technologies to knockout the genes of
interests have been developed, including zinc-ﬁnger nucleases (ZFNs)
(Kim et al. 2011), transcription activator-Like effector nucleases
(TALENs) (Kim et al. 2013), and RNA-guided engineered nucleases
(RGENs) derived from the clustered regularly interspaced short pal-
indromic repeat RNA/CRISPR-associated (CRISPR/Cas) system (Gaj
et al. 2013). Among them, RGENs are the latest gene knockout tools that
were originally identiﬁed as an acquired immunity-like system in bacteria
to protect the host from invading viruses or plasmids (Wiedenheft et al.
2012; Mali et al. 2013).
RGENs consist of three components: Cas9 endonuclease, CRISPR
RNA (crRNA) that complementarily binds to the target site of the
genomic DNA, and trans-activating CRISPR RNA (tracrRNA). This
Cas9/tracrRNA/crRNA tripartite complex or its modiﬁed version, the
bipartite complex consisting of Cas9/chimeric RNA (also called single-
guided RNA or sgRNA), can cleave chromosomal DNA in a targeted
manner and induce mutations efﬁciently in the vicinity of target sites
in model organisms such as mouse, zebraﬁsh, and C. elegans or in cell
lines via the error-prone nonhomologous end-joining (NHEJ) DNA
repair system (Cho et al. 2013a,b; Mali et al. 2013; Wang et al. 2013;
Sung et al. 2014). RGENs were also successfully applied to Drosophila
melanogaster, another major genetic model organism, but with differ-
ences in detailed methodologies; Cas9 was delivered as DNA plasmid
(Gratz et al. 2013), mRNA (Bassett et al. 2013; Yu et al. 2013), or
transgenic expression under a germ-cell–speciﬁc promoter (Kondo
and Ueda 2013; Ren et al. 2013). Similarly, sgRNA was injected as
DNA (Gratz et al. 2013a; Ren et al. 2013), RNA (Bassett et al. 2013;
Yu et al. 2013), and transgenic expression under a universal promoter
(Kondo and Ueda 2013). These approaches showed various efﬁcien-
cies in terms of germ-line transmission rates and the percentages of
mutants in F1 embryos (Gratz et al. 2013b; Bassett and Liu 2014;
Beumer and Carroll 2014).
Here, we used an alternative approach in which the in vitro pre-
formed ribonucleoprotein complex of the puriﬁed Cas9 protein,
in vitro transcribed tracrRNA, and target gene–speciﬁc crRNAs was
injected into the Drosophila embryos to knockout the gene of interest
and validated the mutation-inducing efﬁciency based on the T7 en-
donuclease I (T7E1) assay in G0 founders and F1 mutants. The mu-
tational sequences were later conﬁrmed by direct sequencing. Our
results indicate that our CRISPR/tracrRNA/crRNA complex injection
induced loss-of-function mutations efﬁciently with low toxicity. The
combined usage of the puriﬁed Cas9 protein and the T7E1 assay can
help to validate candidate crRNAs for injection to choose efﬁcient
crRNAs in vitro and in vivo. In addition, the pre-formed ribonucleo-
protein complex consisting of the puriﬁed Cas9 protein/tracrRNA/
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crRNA shown to act immediately after injection and degrade rapidly
may alleviate delayed mutation events, helping reduce off-target effects
and mosaicism by RGENs.
RESULTS AND DISCUSSION
To test whether the tripartite ribonucleoprotein (RNP) complex of
puriﬁed Cas9 protein, tracrRNA, and gene-speciﬁc crRNA (“RGEN-
RNP” below) can generate mutations in the target sites of Drosophila
genome, we ﬁrst chose the ebony (e) gene in the third chromosome
dictating the body color (Figure 1B). We designed two e-speciﬁc
crRNAs that can bind to the second exon upstream of the start codon
(Figure 1A). Syncytial blastoderm-stage w1118 embryos were microin-
jected with each complex of Cas9/RNAs at different concentrations,
grown to adulthood, and individually crossed to D/e, Ser, TM3 to see
if mutations were generated and transmitted through the germline cells
into the F1 generation (see Supporting Information, Figure S1A for the
cross scheme). It was found that the complex with only one of the two
tested crRNAs gave rise to the F1 progeny with the emutant phenotype
(Figure 1B and Table 1). With the injection of crRNA(330 ng)-contain-
ing RGEN-RNP, 26 “G0 founder” ﬂies, deﬁned as adult ﬂies that yielded
at least one F1 mutant, out of 191 ﬂies screened produced the F1
mutants (germline transmission rate, deﬁned as the percentage of G0
founder/G0 adults screened, 26/191 = 13.61%) (Table 1), indicating that
this method is capable of inducing loss-of-function mutations efﬁciently
at target sites. Such rate decreased signiﬁcantly at a higher concentration
of crRNA (660 ng crRNA-containing complex, 2/77 = 2.6%) (Table 1),
suggesting that injected doses of the RGEN-RNP are critical for the
efﬁcient induction of mutations. The percentages of the F1 mutants
in individual F1 offspring clutches from G0 founders varied from
1.8% to 25% with the 330 ng crRNA-containing RGEN-RNP (Table 1).
To detect mutations and evaluate the efﬁciency induced by the
RGEN-RNP on injection, we used the T7E1 assay that can recognize
and cleave mismatched base pairs of wild-type and mutation-
harboring DNA (Kim et al. 2009; see supplementary Materials and
Methods in File S1 for details). Injection of the RGEN-RNP with 330
ng of the e-speciﬁc crRNA produced cleaved bands with various in-
tensities in individual G0 founders by the T7E1 assay (Figure 2A).
Such bands are thought to reﬂect different amounts of mismatched
DNAs mostly due to the somatic mutations in injected individuals.
Germline-transmitted F1 mutants were also conﬁrmed by similar
cleaved patterns but with more distinct bands in the T7E1 assay,
presumably because they are heterozygous for mutations (Figure
2B). These results show that the simple and straightforward T7E1
assay can be used to detect mutations induced by RGEN-RNPs in
the G0 and F1 generations of Drosophila. This assay can be also useful
to decide on the best-working crRNA among multiple candidate
crRNAs when tested in G0 mosaic individuals.
To identify the nature of mutations induced by RGEN-RNP
injection, we subcloned and sequenced the target genomic site of the
ebony gene in the F1 mutant individuals previously conﬁrmed by the
T7E1 assay. A series of small deletion mutations, ranging from 1 base
pair (bp) to 22 bp, was identiﬁed. Most of them cause the early stop of
translation because of out-of-frame mutations and are expected to
generate a nonfunctional protein (Figure 2C).
We further conﬁrmed our RGEN-RNP–mediated gene knockout
method for another gene, singed (sn), which is an X-chromosome
gene that determines bristle formation (Figure 3, A and B). Injection
of RGEN-RNP produced partially gnarled bristles even in the G0
adults as mosaic patterns, suggesting the induction of somatic muta-
tions by sn-speciﬁc RGEN-RNP (Figure 2B and Table 1). Interestingly,
Figure 1 Generating novel ebony mutants us-
ing Cas9 protein/TracrRNA/crRNA complex. (A)
Genomic structure of the ebony gene. The tar-
get nucleotide sequence upstream of the start
codon (red triangle) neighboring the PAM se-
quence is complementary to the 59 end of 20
bp of crRNA (shown in red). TracrRNA and Cas9
protein (shown as yellow circle) form the ribonu-
cleoprotein complex along with gene-speciﬁc
crRNA. (B) Compared to the brown body color
of the wild-type adults (uninjected; left), the eb-
ony F1 mutant (right) shows dark black body
color, the phenotype due to the disrupted eb-
ony gene by the injection of Cas9 protein/
TracrRNA/ebony–speciﬁc crRNA complex.
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one of the three mosaic G0 adult ﬂies was the female ﬂy, indicating the
biallelic mutations in X chromosomes, suggesting high activity of the
injected RGEN-RNP. When injected G0 adult female ﬂies were in-
dividually crossed with wild-type males (Figure S1B) and the gnarled
bristle phenotype was examined in F1 males, it was found that 20%
(4/20, 330-ng crRNA injection) and 7.81% (5/64, 660-ng crRNA
injection) of the G0 adult females carried the loss-of-function muta-
tions in the sn gene of germline cells (Table 1). Direct sequencing
encompassing the sn target site of F1 males conﬁrmed insertion/
deletion (indel) mutations ranging from 51 bp deletion to 2 bp in-
sertion (Figure 3C). Some of these mutations were also conﬁrmed by
the T7E1 assay, showing the cleaved patterns (Figure S2).
Taken together, our results demonstrated that not only the RGEN-
RNP-mediated (consisting of puriﬁed Cas9 protein, tracrRNA, and
gene-speciﬁc crRNA) gene knockout method efﬁciently induces loss-
of-function mutations for the Drosophila genes but also an optimal
dose of the complex is required for its maximal activity because their
knockdown efﬁciency appears to be dose-dependent (Table 1).
In using the CRISPR/Cas9 system to generate Drosophila knock-
outs, our study adopted two methodologies different from previous
approaches: we used the puriﬁed Cas9 protein instead of cas9 DNA
plasmid (Gratz et al. 2013a), in vitro transcribed cas9 RNA (Bassett
et al. 2013; Yu et al. 2013), or germline-speciﬁc nos-cas9 transgenic ﬂy
(Kondo and Ueda 2013; Ren et al. 2013), and we the combined
tracrRNA and gene-speciﬁc crRNA, which were prepared separately
instead of using single-guided (or chimeric) RNA (sgRNA) (Jinek
et al. 2012).
The ribonucleoprotein complex consisting of puriﬁed Cas9 protein
and sgRNA was successfully applied for generating gene knockouts in
C. elegans (Cho et al. 2013) and recently in mice and zebraﬁsh (Sung
n Table 1 Efﬁciency of germline-transmitted mutations
crRNA (ng)
Number of
Injected Embryos
Number of G0 Adults Screened Number of
Mosaic
G0 Adults
Number of
G0 Founder
Germline
Transmission Rate (%)
Percentage of
Mutants in F1
Offspring (%)Female Male
e (660) 400 42 35 0 2 2.6% (2/77) 1.9–3.5
e (330) 900 110 81 0 26 13.61% (26/191) 1.8–25
sn (660) 400 64 53 3 5 7.81% (5/64) 1.7–3.5
sn (330) 400 20 16 3 4 20% (4/20) 2.4–8.4
sn (130) 600 82 74 1 0 0 0
G0 founders yielded at least one F1 mutant, the germline transmission rate is deﬁned as the percentage of G0 founders/G0 adults screened, and the percentage of
mutants in F1 offspring means the percentage of the F1 mutant/F1 adults in each clutch.
Figure 2 Identiﬁcation of ebony mutations by
T7E1 assay and direct sequencing. (A) DNA-
mismatched mutations induced by the injection
of Cas9/RNA complex containing 330 ng of e
crRNA were detected in G0 adult ﬂies by the
T7E1 assay. Each sample consists of two lanes
as a pair in the agarose gel: the left lane is “un-
cut (u),” meaning no treatment, whereas the
right is “cut (c),” digested by the T7E1 endonu-
clease. The numbers on top of each sample
represent independently injected individual
adult ﬂies. The “cut” lanes show additional
lower DNA bands in addition to 400 bp of
uncut PCR-ampliﬁed DNA because mismatched
DNA induced by the Cas9/RNA complex were
digested by the T7E1. Diverse intensities of lower
bands presumably reﬂect different degrees of
mosaic mutations. w2 is the negative control
for the T7E1 assay, whereas e/TM3, heterozygous
for ebony, is the positive control. (B) The T7E1
assay of individual F1 mutant ﬂies. The format of
the gel is similar to (A). The same numbers of
samples in (A) and (B) indicate the relationship
of parents and their offspring. Both w2 and D/
TM3 are negative controls. (C) Direct sequencing
of the target site in individual F1 mutants
revealed various deletion mutations. The num-
bers on the left indicate the individuals in (B) from
which the DNA sequences were derived. Al-
though rare, the deletion and insertion occurred
simultaneously during nonhomologous end-join-
ing DNA repair process (in the case of number
40). CGG in red denotes the PAM sequence.
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et al. 2014), but it has not been tested in Drosophila thus far. The
germline transmission rate (the percentage of G0 founders that yields
at least a single F1 mutant) in our study (ranging from 2.6% to 20%) is
relatively lower than that reported in other species using Cas9 protein/
sgRNA complex (more than 20%) (Sung et al. 2014) and other Dro-
sophila studies using TALEN RNA for trh gene (17% to 39%) (Kondo
et al. 2014), cas9 RNA/sgRNA injection for yellow or w gene (12.4% to
68%) (Bassett et al. 2013, Yu et al. 2013), and germline-speciﬁc nos-
cas9 transgenic expression for w, neuropeptides, and miRNAs (88.2%
to 100%) (Ren et al. 2013; Kondo and Ueda 2013). In contrast, our
germline transmission rate is higher than that using plasmids for cas9
and sgRNA (5%) (Gratz et al. 2013a). The difference in these rates
may originate from the different efﬁciency of sgRNA vs. tracrRNA/
crRNA or the distinctive nature of the target genes tested in different
studies (e.g., some genes are more targetable than others). The in-
herent difference of Drosophila from other species in genome editing
processes may also contribute to such differences. Of note, it has been
reported that the tracrRNA/crRNA combination similar to the one
used in our study is at least as efﬁcient as sgRNA and it may even
contribute to the reduction of off-target effects (Cho et al. 2014),
which is one of the major concerns of the Cas9/RNA system.
Despite the relatively low efﬁciency of the RGEN-RNP injection in
our study compared to the germline-speciﬁc nos-cas9 transgenic sys-
tem or cas9 RNA injection, using the puriﬁed Cas9 protein pre-
formed with tracrRNA/crRNA (or sgRNA) instead of cas9 DNA or
RNA has a few advantages over other methods. First, the transient
activity of the RGEN-RNP system can help alleviate delayed mutation
events on delivery. Continuous expression of cas9 DNA in germ cells
(Kondo and Ueda 2013; Ren et al. 2013) or its fairly stable RNA
injection (Bassett et al. 2013; Sung et al. 2014; Yu et al. 2013) into
developing embryos may elicit mutational events for a prolonged pe-
riod of the development. This can increase the chance of unwanted
off-target effects as well as on-target mutations and mutational mo-
saicism in independent cells of embryos, leading to multiple mutant
alleles in following generations and potentially complicating further
analyses. Contrary to the transgenic expression and RNA injection of
cas9, the action of the puriﬁed Cas9 protein is expected to be rapid
and transient because of its delivery as a form of protein and its short
half-life. We have recently shown in human cell lines that the RGEN-
RNP system acts immediately on delivery and the puriﬁed Cas9 pro-
tein was degraded within 24 hr after being applied to cultured cells
(S. Kim et al. 2014). In this report, we also validated that the RGEN-
Figure 3 Identiﬁcation of novel singed muta-
tions. (A) Genomic structure of the singed gene.
Similar to the ebony gene in Figure 1A, the tar-
get nucleotide sequence neighboring the PAM
sequence is complementary to the 59 end of 20
bp of crRNA (shown in red). TracrRNA and Cas9
protein (shown in yellow circle) singed-speciﬁc
crRNA form the ribonucleoprotein complex. (B)
Compared to the straight bristles of the wild-type
(uninjected; left) the singed F1 mutants show the
gnarled bristles (right), the phenotype due to the
disruption of the singed gene by the injection of
Cas9 protein/TracrRNA/singed–speciﬁc crRNA
complex. Interestingly, this injection leads to
gnarled bristles in some G0 founders in a mosaic
fashion (middle, red circle), indicating somatic
mutations induced by the Cas9/RNA complex.
(C) Direct sequencing of the target site in individ-
ual F1 mutants reveals various insertion/deletion
mutations. The numbers on the left side indicate
individual F1 mutants. Deletions were the pre-
vailing mutations while insertion was identiﬁed
in one individual (blue in number 11). CGG in
red denotes the PAM sequence.
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RNP system induced off-target mutations quite rarely (up to 13-fold
less than Cas9 plasmid did; conﬁrmed by deep sequencing) without
compromising on-target mutation efﬁciency (S. Kim et al. 2014).
However, direct comparisons of mutational mosaicism in animal
models by the RGEN-RNP and other forms of cas9 remain to be
determined.
Another advantage of using the RGEN-RNP system is that
designed sgRNAs or crRNAs can be validated for their efﬁciency for
inducing mutations to select the best ones by using the puriﬁed Cas9
protein in an in vitro cleavage assay before the actual transfection/
injection into cells or embryos is embarked (Sung et al. 2014). Fur-
thermore, such a system can be exploited to genotype the heterozy-
gous and homozygous mutant progenies as an alternative RFLP
(restriction fragment length polymorphism) without requiring speciﬁc
restriction enzymes and recognized sites (J. M. Kim et al. 2014).
However, our RGENP-RNP method requires an additional step of
preparing recombinant Cas9 protein using a bacterial in vitro trans-
lation system (S. Kim et al. 2014), and the relative instability of Cas9
protein compared to DNA or RNA of Cas9 for long-term storage may
be practically problematic.
The selection of target gene–speciﬁc crRNAs or sgRNAs that work
most efﬁciently in vivo among multiple candidates predicted from bio-
informatics is one of the key requirements to generate mutants of
animal models using the CRISPR/Cas9 system. Several methods have
been developed that allow the detection of mutations in the target DNA
induced by genome editing tools in vivo, preferably in the G0 founders.
For example, Bassett et al. (2013) and Gratz et al. (2013a) adopted high-
resolution melting analysis (HRMA) and the surveyor kit (Transge-
nomic, Inc), respectively. The T7E1 assay used in this study is similar
to the surveyor kit in that DNAmismatches are detected by digestion of
a specialized endonuclease, but it is simpler and can detect mutations
using genomic DNA from Drosophila G0 founders (Figure 2).
Our current study proposes a strategy to generate Drosophila
mutants for a certain gene. First, an investigator designs multiple
crRNAs (or sgRNAs) that are predicted to show minimal off-target
effects using web-based software such as http://ﬂyrnai.org/crispr/ (Hsu
et al. 2013) and http://crispr.mit.edu/ (Ren et al. 2013). The potential
off-target sites can be checked at this step (http://www.rgenome.net/
cas-ofﬁnder/) (Bae et al. 2014). Simultaneously, the puriﬁed Cas9
protein is prepared by in vitro translation. Second, the efﬁciency of
multiple crRNAs (or sgRNA) with different doses and ratios with
Cas9 protein are veriﬁed and the best-working ones are selected by
performing the aforementioned in vitro cleavage assay using a RGEN-
RNP (mentioned above) and the T7E1 assay after PCR using genomic
DNA from G0 individuals as the DNA template. If one prefers the
in vivo assay and wants to save time, then the in vitro cleavage assay
can be skipped. Next, G0 founders exhibiting cleaved patterns by the
T7E1 assay are crossed to identify lines that carry germline-transmitted
mutations. Finally, heterozygous and homozygous mutant progenies
in the following generations can be genotyped using either RGEN-
RNP RFLP or T7E1 assays, and the mutagenesis efﬁciency can be
calculated.
In summary, our method reported in this study is a valid alternative
to be considered for generating Drosophila mutants with a reasonable
efﬁciency and as little time and effort as possible, especially when the
prevention of delayed mutation events is preferred to reduce the off-
target effects and mosaicism.
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